{"transactions":[{"id":1959835,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":115707,"kind":"person","name":"Hogge Gary S.","position":1,"cik":"0001771711","reported_name":"Hogge Gary S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP,Clinical & Medical Affairs"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-03-11T00:06:34.000Z","date":"2023-03-09","kind":"grant","acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One quarter of the options shall vest on March 9, 2024, and the balance shall vest in 36 monthly installments thereafter upon the completion of each month of continuous employment."}],"balance_after":400000,"derivative":{"exercise_price":1.46,"expiration_date":"2033-03-09","underlying":"Common Shares","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001493152-23-007310","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315223007310/ownership.xml","form_type":"4"}},{"id":2017876,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":115707,"kind":"person","name":"Hogge Gary S.","position":1,"cik":"0001771711","reported_name":"Hogge Gary S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP,Clinical & Medical Affairs"}}],"security":"Restricted Stock Units","published_at":"2023-02-14T21:15:41.000Z","date":"2023-02-11","kind":"exercise","acquired":false,"shares":13020,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Reporting Person was granted RSUs on February 11, 2022 that vested with respect to 25% of the shares subject to the award on February 11, 2023, and the balance will vest in 3 equal annual installments on each anniversary date thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Reporting Person was granted RSUs on February 11, 2022 that vested with respect to 25% of the shares subject to the award on February 11, 2023, and the balance will vest in 3 equal annual installments on each anniversary date thereafter."}],"balance_after":39061,"derivative":{"exercise_price":0,"underlying":"Common Shares","underlying_shares":13020},"source":{"system":"sec-edgar","filing":"0001493152-23-004895","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315223004895/ownership.xml","form_type":"4"}},{"id":2017875,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":115707,"kind":"person","name":"Hogge Gary S.","position":1,"cik":"0001771711","reported_name":"Hogge Gary S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP,Clinical & Medical Affairs"}}],"security":"Common Shares, no par value","published_at":"2023-02-14T21:15:41.000Z","date":"2023-02-11","kind":"tax_withholding","acquired":false,"shares":5310,"price":1.35,"value":7168.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares withheld by the issuer to satisfy statutory tax withholding requirements on the vesting of 13,020 RSUs in a transaction exempt under Rule 16(b)-3. No shares were sold in connection with this transaction."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Does not include RSUs that may be settled in shares of the issuer's common stock that have not vested as of the date of this Report or shares that may be acquired upon the exercise of certain stock options."}],"balance_after":7710,"source":{"system":"sec-edgar","filing":"0001493152-23-004895","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315223004895/ownership.xml","form_type":"4"}},{"id":2017874,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":115707,"kind":"person","name":"Hogge Gary S.","position":1,"cik":"0001771711","reported_name":"Hogge Gary S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP,Clinical & Medical Affairs"}}],"security":"Common Shares, no par value","published_at":"2023-02-14T21:15:41.000Z","date":"2023-02-11","kind":"exercise","acquired":true,"shares":13020,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares earned by the Reporting Person as a result of the vesting of a portion of Restricted Stock Units (\"RSUs\") granted to the Reporting Person on February 11, 2022. RSUs convert into common shares on a one-for-one basis."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares earned by the Reporting Person as a result of the vesting of a portion of Restricted Stock Units (\"RSUs\") granted to the Reporting Person on February 11, 2022. RSUs convert into common shares on a one-for-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Does not include RSUs that may be settled in shares of the issuer's common stock that have not vested as of the date of this Report or shares that may be acquired upon the exercise of certain stock options."}],"balance_after":13020,"source":{"system":"sec-edgar","filing":"0001493152-23-004895","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315223004895/ownership.xml","form_type":"4"}},{"id":2338638,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":115707,"kind":"person","name":"Hogge Gary S.","position":1,"cik":"0001771711","reported_name":"Hogge Gary S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP,Clinical & Medical Affairs"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-03-12T01:43:46.000Z","date":"2022-03-10","kind":"grant","acquired":true,"shares":450000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One quarter of the options shall vest on March 10, 2023, and the balance shall vest in 36 monthly installments thereafter upon the completion of each month of continuous employment."}],"balance_after":450000,"derivative":{"exercise_price":1.4,"expiration_date":"2032-03-10","underlying":"Common Shares","underlying_shares":450000},"source":{"system":"sec-edgar","filing":"0001493152-22-006696","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315222006696/ownership.xml","form_type":"4"}},{"id":2395604,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":115707,"kind":"person","name":"Hogge Gary S.","position":1,"cik":"0001771711","reported_name":"Hogge Gary S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP,Clinical & Medical Affairs"}}],"security":"Restricted Stock Units","published_at":"2022-02-16T00:42:43.000Z","date":"2022-02-11","kind":"grant","acquired":true,"shares":52081,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Grant of restricted stock units under Lineage's 2021 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one Common Share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to continuous service, vests in four equal annual installments beginning on February 11, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Subject to continuous service, vests in four equal annual installments beginning on February 11, 2023."}],"balance_after":52081,"derivative":{"underlying":"Common Shares","underlying_shares":52081},"source":{"system":"sec-edgar","filing":"0001493152-22-004718","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315222004718/ownership.xml","form_type":"4"}},{"id":2456519,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":115707,"kind":"person","name":"Hogge Gary S.","position":1,"cik":"0001771711","reported_name":"Hogge Gary S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP,Clinical & Medical Affairs"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-12-30T22:20:46.000Z","date":"2021-12-29","kind":"exercise","acquired":false,"shares":9250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The reporting person was granted options on March 17, 2020, with an exercise price of $0.6919 per share to purchase up to 444,000 common shares of the issuer. One quarter of the options vested and became exercisable on March 17, 2021, the first anniversary of the grant date, and the balance vests in 36 monthly installments thereafter upon completion of each month of the reporting person's continuous employment with the issuer."}],"balance_after":249750,"derivative":{"exercise_price":0.6919,"expiration_date":"2030-03-17","underlying":"Common Shares","underlying_shares":9250},"source":{"system":"sec-edgar","filing":"0001493152-21-032897","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315221032897/ownership.xml","form_type":"4"}},{"id":2456518,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":115707,"kind":"person","name":"Hogge Gary S.","position":1,"cik":"0001771711","reported_name":"Hogge Gary S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP,Clinical & Medical Affairs"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-12-30T22:20:46.000Z","date":"2021-12-28","kind":"exercise","acquired":false,"shares":79689,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The reporting person was granted options on February 12, 2019, with an exercise price of $1.14 per share to purchase up to 112,500 common shares of the issuer. One quarter of the options vested and became exercisable on February 12, 2020, the first anniversary of the grant date, and the balance vests in 36 monthly installments thereafter upon completion of each month of the reporting person's continuous employment with the issuer."}],"balance_after":32811,"derivative":{"exercise_price":1.14,"expiration_date":"2029-02-12","underlying":"Common Shares","underlying_shares":79689},"source":{"system":"sec-edgar","filing":"0001493152-21-032897","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315221032897/ownership.xml","form_type":"4"}},{"id":2456517,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":115707,"kind":"person","name":"Hogge Gary S.","position":1,"cik":"0001771711","reported_name":"Hogge Gary S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP,Clinical & Medical Affairs"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-12-30T22:20:46.000Z","date":"2021-12-28","kind":"exercise","acquired":false,"shares":236899,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The reporting person was granted options on February 11, 2018, with an exercise price of $2.11 per share to purchase up to 247,200 common shares of the issuer. One quarter of the options vested and became exercisable on February 11, 2019, the first anniversary of the grant date, and the balance vests in 36 monthly installments thereafter upon completion of each month of the reporting person's continuous employment with the issuer."}],"balance_after":10301,"derivative":{"exercise_price":2.11,"expiration_date":"2028-02-11","underlying":"Common Shares","underlying_shares":236899},"source":{"system":"sec-edgar","filing":"0001493152-21-032897","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315221032897/ownership.xml","form_type":"4"}},{"id":2456516,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":115707,"kind":"person","name":"Hogge Gary S.","position":1,"cik":"0001771711","reported_name":"Hogge Gary S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP,Clinical & Medical Affairs"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-12-30T22:20:46.000Z","date":"2021-12-28","kind":"exercise","acquired":false,"shares":185000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The reporting person was granted options on March 17, 2020, with an exercise price of $0.6919 per share to purchase up to 444,000 common shares of the issuer. One quarter of the options vested and became exercisable on March 17, 2021, the first anniversary of the grant date, and the balance vests in 36 monthly installments thereafter upon completion of each month of the reporting person's continuous employment with the issuer."}],"balance_after":259000,"derivative":{"exercise_price":0.6919,"expiration_date":"2030-03-17","underlying":"Common Shares","underlying_shares":185000},"source":{"system":"sec-edgar","filing":"0001493152-21-032897","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315221032897/ownership.xml","form_type":"4"}},{"id":2456515,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":115707,"kind":"person","name":"Hogge Gary S.","position":1,"cik":"0001771711","reported_name":"Hogge Gary S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP,Clinical & Medical Affairs"}}],"security":"Common Shares, no par value","published_at":"2021-12-30T22:20:46.000Z","date":"2021-12-29","kind":"sale","acquired":false,"shares":28445,"price":2.44,"value":69405.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average. These shares were sold in multiple transactions at prices ranging from $2.42 to not more than $2.52. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001493152-21-032897","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315221032897/ownership.xml","form_type":"4"}},{"id":2456514,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":115707,"kind":"person","name":"Hogge Gary S.","position":1,"cik":"0001771711","reported_name":"Hogge Gary S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP,Clinical & Medical Affairs"}}],"security":"Common Shares, no par value","published_at":"2021-12-30T22:20:46.000Z","date":"2021-12-29","kind":"sale","acquired":false,"shares":9250,"price":2.49,"value":23032.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The 9,250 shares sold on 12/29/21, were all sold at a transaction price of $2.49."}],"balance_after":28445,"source":{"system":"sec-edgar","filing":"0001493152-21-032897","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315221032897/ownership.xml","form_type":"4"}},{"id":2456513,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":115707,"kind":"person","name":"Hogge Gary S.","position":1,"cik":"0001771711","reported_name":"Hogge Gary S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP,Clinical & Medical Affairs"}}],"security":"Common Shares, no par value","published_at":"2021-12-30T22:20:46.000Z","date":"2021-12-29","kind":"exercise","acquired":true,"shares":9250,"price":0.6919,"value":6400.075,"ownership":{"direct":true},"balance_after":37695,"source":{"system":"sec-edgar","filing":"0001493152-21-032897","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315221032897/ownership.xml","form_type":"4"}},{"id":2456512,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":115707,"kind":"person","name":"Hogge Gary S.","position":1,"cik":"0001771711","reported_name":"Hogge Gary S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP,Clinical & Medical Affairs"}}],"security":"Common Shares, no par value","published_at":"2021-12-30T22:20:46.000Z","date":"2021-12-28","kind":"sale","acquired":false,"shares":501588,"price":2.45,"value":1228890.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average. These shares were sold in multiple transactions at prices ranging from $2.40 to not more than $2.53. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."}],"balance_after":28445,"source":{"system":"sec-edgar","filing":"0001493152-21-032897","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315221032897/ownership.xml","form_type":"4"}},{"id":2456511,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":115707,"kind":"person","name":"Hogge Gary S.","position":1,"cik":"0001771711","reported_name":"Hogge Gary S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP,Clinical & Medical Affairs"}}],"security":"Common Shares, no par value","published_at":"2021-12-30T22:20:46.000Z","date":"2021-12-28","kind":"exercise","acquired":true,"shares":79689,"price":1.14,"value":90845.46,"ownership":{"direct":true},"balance_after":530033,"source":{"system":"sec-edgar","filing":"0001493152-21-032897","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315221032897/ownership.xml","form_type":"4"}},{"id":2456510,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":115707,"kind":"person","name":"Hogge Gary S.","position":1,"cik":"0001771711","reported_name":"Hogge Gary S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP,Clinical & Medical Affairs"}}],"security":"Common Shares, no par value","published_at":"2021-12-30T22:20:46.000Z","date":"2021-12-28","kind":"exercise","acquired":true,"shares":236899,"price":2.11,"value":499856.89,"ownership":{"direct":true},"balance_after":450344,"source":{"system":"sec-edgar","filing":"0001493152-21-032897","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315221032897/ownership.xml","form_type":"4"}},{"id":2456509,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":115707,"kind":"person","name":"Hogge Gary S.","position":1,"cik":"0001771711","reported_name":"Hogge Gary S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP,Clinical & Medical Affairs"}}],"security":"Common Shares, no par value","published_at":"2021-12-30T22:20:46.000Z","date":"2021-12-28","kind":"exercise","acquired":true,"shares":185000,"price":0.6919,"value":128001.5,"ownership":{"direct":true},"balance_after":213445,"source":{"system":"sec-edgar","filing":"0001493152-21-032897","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315221032897/ownership.xml","form_type":"4"}},{"id":2784203,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":115707,"kind":"person","name":"Hogge Gary S.","position":1,"cik":"0001771711","reported_name":"Hogge Gary S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP,Clinical & Medical Affairs"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-03-17T21:00:45.000Z","date":"2021-03-15","kind":"grant","acquired":true,"shares":419500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One quarter of the options shall vest on March 15, 2022 and the balance shall vest in 36 monthly installments thereafter upon the completion of each month of continuous employment."}],"balance_after":419500,"derivative":{"exercise_price":2.43,"expiration_date":"2031-03-15","underlying":"Common Shares","underlying_shares":419500},"source":{"system":"sec-edgar","filing":"0001493152-21-006270","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315221006270/ownership.xml","form_type":"4"}},{"id":3201265,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":115707,"kind":"person","name":"Hogge Gary S.","position":1,"cik":"0001771711","reported_name":"Hogge Gary S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP,Clinical & Medical Affairs"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-03-19T21:00:15.000Z","date":"2020-03-17","kind":"grant","acquired":true,"shares":444000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One quarter of the options shall vest on March 17, 2021 and the balance shall vest in 36 monthly installments thereafter upon the completion of each month of continuous employment."}],"balance_after":444000,"derivative":{"exercise_price":0.6919,"expiration_date":"2030-03-17","underlying":"Common Shares","underlying_shares":444000},"source":{"system":"sec-edgar","filing":"0001493152-20-004350","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315220004350/ownership.xml","form_type":"4"}}]}